AdvisorShares Psychedelics ETF (PSIL) Holdings → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free PSIL Stock Alerts $1.29 +0.01 (+0.78%) (As of 05/3/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Top 27 PSIL HoldingsRankCompanyCurrent PriceWeightShares Held1MNMDMind Medicine (MindMed)$10.00+5.0%14.76%120,3142Cybin Inc Ordinary SharesN/A9.30%1,807,2933CMPSCOMPASS Pathways$8.53+3.4%6.93%58,9924ATAIAtai Life Sciences$2.05-3.8%5.43%200,2075VTGNVistagen Therapeutics$4.50+2.0%5.42%79,2426GHRSGH Research$11.68+4.4%5.32%33,093 Get the Latest News and Ratings for PSIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. 7ITCIIntra-Cellular Therapies$68.80-2.2%5.28%4,9798BlackRock Liquidity Treasury InstlN/A4.80%331,2349NRXPNRx Pharmaceuticals$2.10+1.9%4.75%105,04310ALKSAlkermes$24.05+0.8%4.73%13,23011RLMDRelmada Therapeutics$3.68-1.1%4.31%77,02212ENVBEnveric Biosciences$0.98+5.4%3.78%278,83313PBMPsyence Biomedical$1.16-8.7%3.78%325,70814SAGESage Therapeutics$13.94+6.3%3.15%15,52615FSD Pharma Inc Ordinary Shares - Class B (Sub Voting)N/A3.11%467,92216Bright Minds Biosciences Inc Ordinary SharesN/A2.78%176,03817SEELSeelos Therapeutics$0.34+3.0%2.51%575,09918CMNDClearmind Medicine$1.19+1.7%2.24%128,64119Numinus Wellness Inc.N/A2.23%2,590,24020IXHLIncannex Healthcare$2.39-6.3%1.83%55,97621LSDILucy Scientific Discovery$0.82+1.2%1.62%124,16322GBNHFGreenbrook TMS$0.11+10.3%1.61%1,109,76323PsyBio Therapeutics Corp Ordinary SharesN/A0.32%2,994,81724CashN/A0.00%125Celly NutritionN/A0.00%263,23626Field Trip Health & Wellness Ltd Ordinary SharesN/A0.00%1,058,41527U.S. DollarN/A0.00%1 Geographic ExposureUnited States50.3%Canada12.9%Ireland10.1%Netherlands5.9%Currency ExposureUSD97.1%CAD3.6%Sector ExposureHealth Care12.5%Industry ExposureBiotechnology12.5%SubIndustry ExposureBiotechnology12.5%Coupon Exposure4-63.9% Related Companies and Tools Related Companies: DMAT Portfolio IDAT Portfolio EQUL Portfolio VICE Portfolio BTHM Portfolio EV Portfolio EMDM Portfolio NSI Portfolio TCHI Portfolio NIKL Portfolio This page (NYSEARCA:PSIL) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
